# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division 1.1.3: Physico-chemical characteristics liable to affect bioavailability

Extent: E+W+S+N.I.

The following items of information concerning active substances, whether or not listed in the pharmacopoeias, shall be provided as part of the general description of the active substances if the bioavailability of the veterinary medicinal product depends on them:
crystalline form and solubility coefficients,
particle size, where appropriate after pulverisation,
state of hydration,
oil/water coefficient of partition,
pK/pH values.
The first three indents are not applicable to substances used solely in solution.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/I/part/2/division/C/division/1/division/1.1/division/1.1.3 (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-I/part-2/division-C/division-1/division-1.1/division-1.1.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

